Authors’ Reply to the Letter to the Editor by Nguyen et al

Authors:
Xudong Ni Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Shanghai Genitourinary Cancer Institute, Shanghai, China

Search for other papers by Xudong Ni in
Current site
Google Scholar
PubMed Close
 MD
and
Yao Zhu Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
Shanghai Genitourinary Cancer Institute, Shanghai, China

Search for other papers by Yao Zhu in
Current site
Google Scholar
PubMed Close
 MD, PhD
Volume/Issue:
Volume 21: Issue 11
Online Publication Date:
Nov 2023
DOI:
https://doi.org/10.6004/jnccn.2023.7092
Restricted access
  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
  • 1.

    Nguyen DD, Kwong JCC, Zlotta AR, Wallis CJD. Letter to the editor: disaggregating Asian prostate cancer cohorts can help us improve care for all prostate cancer patients. J Natl Compr Canc Netw 2023;21:xli.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Ni X, Luu M, Ma W, et al. Impact of Asian race on prognosis in de novo metastatic prostate cancer. J Natl Compr Canc Netw 2023;21:733–741e3.

  • 3.

    Chen MS, Lee RJ, Madan RA, et al. Charting a path towards asian american cancer health equity: a way forward. J Natl Cancer Inst 2022;114:792–799.

  • 4.

    Zhu Y, Mo M, Wei Y, et al. Epidemiology and genomics of prostate cancer in Asian men. Nat Rev Urol 2021;18:282–301.

  • 5.

    Saad F, Clarke NW, Oya M, et al. Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial. Lancet Oncol. Published online September 12, 2023. doi:10.1016/S1470-2045(23)00382-0

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Li J, Xu C, Lee HJ, et al. A genomic and epigenomic atlas of prostate cancer in Asian populations. Nature 2020;580:93–99.

  • 7.

    Chua MLK, Hakansson AK, Ong EHW, et al. Transcriptomic analyses of localized prostate cancers of East Asian and North American men reveal race-specific luminal-basal and microenvironmental differences. Cancer Commun (Lond). Published online September 12, 2023. doi:10.1002/cac2.12467

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Wei Y, Zhang T, Wang B, et al. Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity. Mol Oncol. Published online August 16, 2023. doi:10.1002/1878-0261.13511

    • PubMed
    • Search Google Scholar
    • Export Citation
Copyright:
Copyright © 2023 by the National Comprehensive Cancer Network 2023
Article Category:
Reply
Print Publication Date:
01 Nov 2023
Online Publication Date:
Nov 2023

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 2945 2945 22
PDF Downloads 530 530 26
EPUB Downloads 0 0 0